Company overview

We are a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine disease and endocrine-related tumors. Driven by the belief that no one should be defined by their disease, we’re transforming endocrine care to significantly improve the lives of patients, caregivers, and loved ones. As the premier, endocrine-rooted pharmaceutical company, we’re shaping the future of treatment, empowering individuals to live beyond their condition, and thrive. For information on our social media guidelines, please visit: https://crinetics.com/social-media-community-guidelines/Notice of Fraudulent Activity for Job Applicants: Please be aware of fraudulent communications you might receive from job posting sites or via email. Bad actors may try to impersonate Crinetics’ Talent Acquisition team, and their messages may appear legitimate. We strongly recommend that you verify all communications you receive about positions at Crinetics. If you are unsure about a posting or email you receive, please contact us at talentacquisition@crinetics.com. If you believe you are a victim of fraud, please contact your local law enforcement.
Founded in 2008
San Diego, California, USA
564 employees (27 in marketing)
54% recommend to a friend
87% positive business outlook

Salaries

Typical salary range

$193,000 – $241,000

/ yr

Help build salary transparency at Crinetics Pharmaceuticals

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

3 open now

Headcount trend

Company growth over the last 12 months

Headcount +47.9% year over year

Funding

Total funding

$2B

Last raise

$349.2M

Post IPO Equity, 2 months ago

Funding history

Jan 2026

Post IPO Equity Crinetics Pharmaceuticals · $349.2M

Oct 2024

Post IPO Equity Crinetics Pharmaceuticals · $500M

Feb 2024

Post IPO Equity Crinetics Pharmaceuticals · $350M

Sep 2023

Post IPO Equity Crinetics Pharmaceuticals · $350M

Apr 2022

Post IPO Equity Crinetics Pharmaceuticals · $125M

Jul 2021

Post IPO Equity Crinetics Pharmaceuticals · $15M

Audience

Monthly website visitors
26K
Month over month+50%
Quarter over quarter+67.7%
Top sourceSearch (47.8%)
Ad budget per month$10.7
Average search rank47.1
Traffic source mix
Search
47.8%
Direct
38.9%
Referral
7.3%
Social
4.3%
Paid referral
1.4%

LinkedIn followers

Follower count and growth

Total followers

47.8K

12-mo growth

+86.8%

Monthly growth

+5.2%

News

Links